The Health Planning Commission requires the medical and health industry to focus on punishing bribery in the purchase and sale of medicines.


Release time:

2015-04-01


An inter-ministerial joint meeting on correcting unhealthy tendencies in pharmaceutical purchase and sale and medical services was held at the National Health and Family Planning Commission a few days ago, focusing on punishing commercial bribery in the field of pharmaceutical purchase and sale.
Li Bin, director of the State Health and Family Planning Commission, asked all member units to concentrate on solving difficult and key problems and grasp the outstanding problems strongly reflected by the people. The first is to focus on punishing commercial bribery in the field of pharmaceutical purchase and sale, the second is to strengthen the rectification of problems related to the safety of people's lives and property, and the third is to actively deal with the new situation and new problems in the process of medical reform. Li Bin requested that, on the one hand, we must continue to maintain the high-pressure situation of investigating and handling cases, and in-depth control of commercial bribery in the field of pharmaceutical purchases and sales; on the other hand, we must deepen reforms and strengthen the construction of the regulatory system to promote a fundamental improvement in the industry.
In addition, at the National Drug Administration Work Conference held a few days ago, Sun Zhigang, deputy director of the National Health and Family Planning Commission, said that this year, the construction standards of the provincial drug centralized procurement platform will be unified, the standardization of drug procurement codes will be promoted, and the national drug supply guarantee comprehensive management information platform will be realized within this year. Interconnection and resource sharing with all provinces.